Andraz Perhavec
Overview
Explore the profile of Andraz Perhavec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ratosa I, Bavdaz M, Bonca P, Logar H, Perhavec A, Skubic M, et al.
Radiol Oncol
. 2025 Jan;
59(1):31-42.
PMID: 39754600
Background: Breast cancer is one of the most common cancers, increasingly prevalent also among working-age populations. Regardless of age, breast cancer has significant direct and indirect costs on the individuals,...
2.
Montagna G, Laws A, Ferrucci M, Mrdutt M, Sun S, Bademler S, et al.
J Clin Oncol
. 2024 Nov;
43(7):810-820.
PMID: 39509672
Purpose: The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management is not...
3.
Pislar N, Gasljevic G, Matos E, Pilko G, Zgajnar J, Perhavec A
Breast Cancer Res Treat
. 2024 Nov;
210(1):87-94.
PMID: 39496911
Purpose: To generate a model for predicting nodal response to neoadjuvant systemic treatment (NAST) in biopsy-proven node-positive breast cancer patients (cN+) that incorporates tumor microenvironment (TME) characteristics and could be...
4.
Ramanovic M, Novak M, Perhavec A, Jordan T, Popuri K, Kozjek N
Radiol Oncol
. 2024 Feb;
58(1):110-123.
PMID: 38378038
Background: Retroperitoneal sarcomas (RPS) are rare tumours of mesenchymal origin, commonly presented as a large tumour mass at time of diagnosis. We investigated the impact of body composition on outcome...
5.
Pislar N, Gasljevic G, Marolt Music M, Borstnar S, Zgajnar J, Perhavec A
World J Surg Oncol
. 2023 Sep;
21(1):292.
PMID: 37715188
Background: In node-positive breast cancer patients at diagnosis (cN +) that render node-negative after neoadjuvant systemic treatment (NAST), axillary lymph node dissection (ALND) can be avoided in selected cases. Axillary...
6.
Pislar N, Gasljevic G, Ratosa I, Kovac A, Zgajnar J, Perhavec A
Breast Cancer Res Treat
. 2023 Sep;
202(3):443-450.
PMID: 37679645
Purpose: To determine whether the absence of post-treatment changes in the negative sentinel lymph nodes (SLN) in the neoadjuvant setting for biopsy-proven cN + disease results in an increased regional...
7.
Reijers S, Davies E, Grunhagen D, Fiore M, Honore C, Rastrelli M, et al.
Eur J Cancer
. 2023 Jul;
190:112949.
PMID: 37453241
Objective: The aim of this study was to investigate the response rates of different extremity soft-tissue sarcoma subtypes (eSTS) after isolated limb perfusion (ILP), based on an international multi-centre study....
8.
Noh S, Nessim C, Keung E, Roland C, Strauss D, Sivarajah G, et al.
Ann Surg
. 2022 Jul;
278(2):267-273.
PMID: 35866666
Objective: The Transatlantic Australasian Retroperitoneal Sarcoma Working Group conducted a retrospective study on the disease course and clinical management of ganglioneuromas. Background: Ganglioneuromas are rare tumors derived from neural crest...
9.
Pislar N, Peric B, Ahcan U, Cencelj-Arnez R, Zgajnar J, Perhavec A
Radiol Oncol
. 2022 Jul;
57(1):80-85.
PMID: 35853741
Background: Women who undergo breast cancer surgery often have an indication for gynaecological procedure. The aim of our study was to compare infectious complications rate after mastectomy with implant-based reconstruction...
10.
Hadalin V, Pislar N, Borstnar S, Matos E, Kovac A, Dobovisek L, et al.
Clin Breast Cancer
. 2022 Jan;
22(4):e597-e603.
PMID: 35086763
Background: Intraoperative touch imprint cytology (ITIC) is used for intraoperative detection of sentinel lymph node (SLN) metastases with intention to spare the patients another surgery. However, ITIC prolongs surgery, and...